(S1 (S (NP (NP (NP (NN Isolation)) (CC and) (NP (NN culture))) (PP (IN of) (NP (JJ primary) (JJ CD8+) (NN T) (NNS cells))) (. .))))
(S1 (S (S (NP (NP (JJ CD8+) (NN T) (NNS cells)) (PP (IN from) (NP (NP (NP (NP (JJ 4-8-wk-old) (JJ Tcra-/-) (NN x) (NN P14) (NN TCR) (JJ transgenic)) (PRN (-LRB- -LRB-) (NP (NN Taconic)) (-RRB- -RRB-))) (, ,) (NP (NN C57BL/6J) (NN WT)) (, ,) (CC or) (NP (NP (JJ Tbx21-/-)) (PRN (-LRB- -LRB-) (NP (NNP The) (NNP Jackson) (NN Laboratory)) (-RRB- -RRB-)))) (NNS mice)))) (VP (VBD were) (VP (VBN purified) (PRN (-LRB- -LRB-) (NP (NN >) (CD 95) (NN %) (NN purity)) (-RRB- -RRB-)) (PP (IN by) (NP (NP (JJ negative) (NN selection)) (PRN (-LRB- -LRB-) (NP (NNP Invitrogen)) (-RRB- -RRB-)))) (PP (IN from) (NP (NP (NP (JJ pooled) (NN spleen)) (CC and) (NP (NN lymph) (NN node))) (NNS cells)))))) (. .)))
(S1 (S (S (NP (NP (JJ CD8+) (NN T) (NNS cells)) (PP (IN from) (NP (NP (JJ Runx3-/-) (NNS mice)) (PP (IN on) (NP (DT the) (NN ICR) (NN background)))))) (VP (VBD were) (VP (VBN purified) (PP (IN by) (NP (NP (JJ positive) (NN selection)) (PRN (-LRB- -LRB-) (NP (NNP Miltenyi) (NNP Biotec)) (-RRB- -RRB-))))))) (. .)))
(S1 (S (S (NP (DT All) (NNS mice)) (VP (VBD were) (VP (VP (VBN maintained) (PP (IN in) (NP (JJ specific) (JJ pathogen-free) (NN barrier) (NNS facilities)))) (CC and) (VP (VBN used) (PP (VBG according) (PP (TO to) (NP (NP (NP (NNS protocols)) (ADJP (JJ approved) (PP (IN by) (NP (DT the) (JJ Immune) (NN Disease) (NN Institute))))) (CC and) (NP (NP (NP (DT the) (NN Harvard) (JJ Medical) (NN School) (NN Animal) (NN Care)) (CC and) (NP (NN Use))) (NNS Committees))))))))) (. .)))
(S1 (S (PP (IN For) (NP (NN stimulation))) (, ,) (NP (VBN purified) (JJ CD8+) (NN T) (NNS cells)) (VP (VBD were) (VP (VBN cultured) (PP (IN at) (NP (NP (CD 106) (NNS cells/ml)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN ml)) (-RRB- -RRB-)))) (PP (IN in) (NP (NP (NP (NN T25) (NNS flasks)) (VP (VBN coated) (PP (IN with) (NP (CD 1) (NN mug/ml))))) (NP (NP (DT each)) (PP (IN of) (NP (NP (NP (NN anti-CD3)) (PRN (-LRB- -LRB-) (NP (NN clone) (NN 2C11)) (-RRB- -RRB-))) (CC and) (NP (NP (NN anti-CD28)) (PRN (-LRB- -LRB-) (NP (NN clone) (NN 37.51)) (-RRB- -RRB-)))))))) (PP (IN by) (NP (NP (NN pretreatment)) (PP (IN with) (NP (CD 300) (NN mug/ml) (NN goat) (NN anti-hamster) (NN IgG))))))) (. .)))
(S1 (S (S (PP (IN After) (NP (CD 48) (NN h))) (, ,) (NP (NNS cells)) (VP (VBD were) (VP (VP (VBN removed) (PP (IN from) (NP (DT the) (NN TCR) (NN stimulation)))) (CC and) (VP (VBN recultured) (PP (IN at) (NP (NP (DT a) (NN concentration)) (PP (IN of) (NP (QP (CD 5) (CC x) (CD 105)) (NNS cells/ml))) (PP (IN in) (NP (NP (NNS media)) (VP (VBN supplemented) (PP (IN with) (NP (ADJP (CD 100) (NN U/ml)) (NN rhIL-2)))))))))))) (. .)))
(S1 (S (S (NP (NP (DT Every) (NP (CD 24) (NN h))) (, ,) (NP (JJ viable) (NNS cells))) (VP (VBD were) (VP (VP (VBN counted)) (CC and) (VP (VBN readjusted) (PP (TO to) (NP (QP (CD 5) (CC x) (CD 105)) (NNS cells/ml))) (PP (IN with) (NP (NP (JJ fresh) (NNS media)) (VP (VBG containing) (NP (NP (DT the) (JJ corresponding) (NN amount)) (PP (IN of) (NP (NN rhIL-2))))))))))) (. .)))
